We investigate the determinants of University-Industry (U-I) interactions in the biopharmaceuticals in Italy over the period 2004-2010, choosing co-publishing as a proxy of U-I partnerships. We construct a novel dataset of co-published articles, that contains measures of proximities, agglomeration, firms' and universities' characteristics. Following a consolidated methodology, we integrate our dataset of effective interactions with the set of all potential interactions, to estimate probabilistic models for the occurrence and the intensity of U-I interactions. Our main findings confirm and extend the predictions of the previous literature: (1) geographical proximity and prior partnership increase the probability and the intensity of co-publication; (2) the proximity of a firm to other biopharmaceutical firms and universities attenuates the relevance of geographical proximity; (3) there exists complementarity between prior partnerships and geographical proximity. A novel result is that firms' and Universities' size, firms' R&D and patents expenditure and the composition of the academic staff as well as quality of academic research exert a significant impact on the intensity of co-publishing.
University-Industry collaboration in the biopharmaceuticals: The Italian Case
PIERUCCI, ELEONORA
2016-01-01
Abstract
We investigate the determinants of University-Industry (U-I) interactions in the biopharmaceuticals in Italy over the period 2004-2010, choosing co-publishing as a proxy of U-I partnerships. We construct a novel dataset of co-published articles, that contains measures of proximities, agglomeration, firms' and universities' characteristics. Following a consolidated methodology, we integrate our dataset of effective interactions with the set of all potential interactions, to estimate probabilistic models for the occurrence and the intensity of U-I interactions. Our main findings confirm and extend the predictions of the previous literature: (1) geographical proximity and prior partnership increase the probability and the intensity of co-publication; (2) the proximity of a firm to other biopharmaceutical firms and universities attenuates the relevance of geographical proximity; (3) there exists complementarity between prior partnerships and geographical proximity. A novel result is that firms' and Universities' size, firms' R&D and patents expenditure and the composition of the academic staff as well as quality of academic research exert a significant impact on the intensity of co-publishing.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
